Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

855 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Taiwan-Asia Semiconductor Corporation Announces Executive Changes
CI
Taiwan-Asia Semiconductor Corporation Announces Chief Financial Officer Changes
CI
Transcript : Bilibili Inc., Q1 2024 Earnings Call, May 23, 2024
Bilibili : Quarterly Earnings Documents
PU
Bilibili Inc. Announces First Quarter 2024 Financial Results
AQ
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine
NE
GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease
BU
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
NE
ATRenew Inc. Announces Appointment of New Director
AQ
ATRenew Inc. Announces Board and Committee Changes
CI
Certain A Shares of Shenzhen Injoinic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-APR-2024.
CI
Netflix : Chinese-Language Revenge Thriller Series ‘The Resurrected’ Marks International Film Stars Shu Qi and Sinje Lee’s Debut on Netflix →
PU
Bilibili : Quarterly Earnings Documents
PU
Bilibili Publishes 2023 Environmental, Social and Governance Report
AQ
Certain A Shares of Anhui Yuanchen Environmental Protection Science&Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 31-MAR-2024.
CI
Certain Common Stock of NETSTARS Co.,Ltd. are subject to a Lock-Up Agreement Ending on 23-MAR-2024.
CI
Transcript : Evolus, Inc., Q4 2023 Earnings Call, Mar 07, 2024
Transcript : Bilibili Inc., Q4 2023 Earnings Call, Mar 07, 2024
Bilibili Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
AQ
Transcript : NIO Inc., Q4 2023 Earnings Call, Mar 05, 2024
Tuniu Corporation Announces Executive Changes
CI
Transcript : CapitaLand Investment Limited, 2023 Earnings Call, Feb 28, 2024
IDT International Limited Announces Board Changes
CI
Certain A Shares of Jinko Solar Co., Ltd. are subject to a Lock-Up Agreement Ending on 27-JAN-2024.
CI
Zhejiang Taitan Co.,Ltd. Approves Board Elections
CI
Certain Common Stock of NETSTARS Co.,Ltd. are subject to a Lock-Up Agreement Ending on 24-DEC-2023.
CI
Transcript : NIO Inc., Q3 2023 Earnings Call, Dec 05, 2023
Transcript : Bilibili Inc., Q3 2023 Earnings Call, Nov 29, 2023
Bilibili Inc. Announces Third Quarter 2023 Financial Results
AQ
ZTE : hosts Analyst Conference 2023 in Thailand, paving the way for digital economy advancements
PU
Transcript : Evolus, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Certain A Shares of Jiangsu Rijiu Optoelectronics Jointstock Co., Ltd are subject to a Lock-Up Agreement Ending on 21-OCT-2023.
CI
Gambol Pet Group Co., Ltd. Announces Executive Appointments
CI
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.
CI
Certain A Shares of Wuhan Keqian Biology Co.,Ltd are subject to a Lock-Up Agreement Ending on 22-SEP-2023.
CI
Certain A Shares of KENGIC Intelligent Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 15-SEP-2023.
CI
PharmaDrug Provides Development Update of Cepharanthine (PD-001) for Cancer and Infectious Disease
NE
IDreamSky Technology Holdings Limited Announces Board and Committee Changes
CI
”Umamusume: Pretty Derby” Simplified Chinese Version Launches on August 30, 2023
PU
Transcript : IHH Healthcare Berhad, Q2 2023 Earnings Call, Aug 30, 2023
Bilibili : Quarterly Earnings Documents
PU
Transcript : Bilibili Inc., Q2 2023 Earnings Call, Aug 17, 2023
Bilibili Inc. Announces Second Quarter 2023 Financial Results
AQ
Transcript : Evolus, Inc., Q2 2023 Earnings Call, Aug 02, 2023
Zai Lab Announces First Patient Treated in Mainland China for the Global Phase 3 FORTITUDE-101 Study of Bemarituzumab in First-Line Gastric Cancer
GL
Anhui Huaren Health Pharmaceutical Co., Ltd. signed a letter of intent to acquire 60% stake in Zhoushan Liken Pharmaceutical Chain Co Ltd from Wang Xiangan and Zhejiang Free Trade Zone Xueyuan Project Investment Partnership for approximately CNY 110 million.
CI
Bilibili : GRANT OF RESTRICTED SHARE UNITS - Form 6-K
PU
Transcript : 36Kr Holdings Inc., Q1 2023 Earnings Call, Jun 06, 2023
Transcript : Bilibili Inc., Q1 2023 Earnings Call, Jun 01, 2023
Bilibili's First-Quarter Loss Narrowed on Continuing Cost Cuts
DJ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Chen Rui
  4. News